Emmessar Biotech And Nutrition Profile
Key Indicators
- Authorised Capital ₹ 5.40 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.10 Cr
- Revenue Growth 21.29%
- Profit Growth 5.98%
- Ebitda 22.87%
- Net Worth 8.03%
- Total Assets 10.11%
About Emmessar Biotech And Nutrition
Emmessar Biotech And Nutrition Ltd (EBANL) is a Public Limited Indian Non-Government Company incorporated in India on 17 March 1992 and has a history of 32 years and 11 months. Its registered office is in Raigarh, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524768.
The Corporate was formerly known as Emmessar Chmical Industries Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.40 Cr and a paid-up capital of Rs 5.00 Cr.
The company has closed loans amounting to ₹1.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Emmessar Biotech And Nutrition Ltd India are Jeyavel Nadar as CFO and Priyanka Sharma as Company Secretary. Anantharama Subramanian, Dinesh Deora, Milind Desai, and Six other members serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24110MH1992PLC065942
- Company No.
065942
- Stock Symbol
BSE : 524768
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 1992
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Emmessar Biotech And Nutrition Ltd offer?
Emmessar Biotech And Nutrition Ltd offers a wide range of products and services, including Herbal Cough Syrup, Tulsi Cough Syrup, Skin Care Cosmetics, Skin Gel, Body Care Products, Body Lotions.
Who are the key members and board of directors at Emmessar Biotech And Nutrition?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jeyavel Nadar ![]() | CFO | 02-Feb-2019 | Current |
Priyanka Sharma ![]() | Company Secretary | 12-Dec-2020 | Current |
Raghavan Ayyangar ![]() | Managing Director | 17-Mar-1992 | Current |
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Milind Desai ![]() | Director | 20-Oct-2022 | Current |
Sarada Raghavan ![]() | Director | 12-Aug-2013 | Current |
Anantharama Subramanian ![]() | Director | 06-Nov-2020 | Current |
Dinesh Deora ![]() | Director | 15-Apr-2024 | Current |
Anuradha Raghavan ![]() | Director | 12-Aug-2013 | Current |
Jeyavel Nadar ![]() | Whole-Time Director and Cfo | 06-Feb-2021 | Current |
Financial Performance of Emmessar Biotech And Nutrition.
Emmessar Biotech And Nutrition Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 21.29% increase. The company also saw a slight improvement in profitability, with a 5.98% increase in profit. The company's net worth moved up by a moderate rise of 8.03%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Emmessar Biotech And Nutrition?
In 2023, Emmessar Biotech And Nutrition had a promoter holding of 59.08% and a public holding of 40.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹1.10 Cr
Charges Breakdown by Lending Institutions
- Idbi Bank : 1.10 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
16 Dec 1994 | Idbi Bank | ₹1.10 Cr | Satisfied |
How Many Employees Work at Emmessar Biotech And Nutrition?
Emmessar Biotech And Nutrition has a workforce of 14 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Emmessar Biotech And Nutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emmessar Biotech And Nutrition's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.